XHEvsBBPETF Comparison
VS
State Street SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. XHE's top 2 sector exposures are Healthcare and Finance. In contrast, BBP's top sector exposures are Healthcare. XHE is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.34% for BBP. XHE is up 5.54% year-to-date (YTD) with -$11M in YTD flows. BBP performs better with 28.1% YTD performance, and +$66M in YTD flows. Run a side-by-side ETF comparison of XHE and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XHE vs BBP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XHE BBP | +1.87%-2.17% | +9.46%+5.26% | +5.54%+28.10% | +14.34%+41.42% | +33.01%+121.19% | -25.86%+99.68% |
| Flows | XHE BBP | -$45M+$5M | -$15M+$26M | -$11M+$66M | -$21M+$78M | -$225M+$83M | -$401M+$76M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XHE BBP | +20.85%+28.19% | +22.71%+26.47% | +21.97%+25.00% | +24.86%+26.86% |
| Max drawdown | XHE BBP | -9.09%-8.70% | -18.20%-9.59% | -24.35%-25.54% | -49.37%-37.61% |
| Max drawdown duration | XHE BBP | 65d65d | 207d48d | 565d292d | 1815d586d |
Trading data
XHE | BBP | |
Last sale 10/26/2026 at 1:30 PM | $93.09 | $102.33 |
| Previous close 10/23/2026 | $93.08 | $102.07 |
| Consolidated volume 10/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XHE | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/26/2026 at 1:30 PM
Live
Closed
XHE | BBP | |
|---|---|---|
| Last price | $93.09 | $102.33 |
| 1D performance | +0.01% | +0.26% |
| AuM | $151.14 M | $127.72 M |
| E/R | 0.35% | 0.34% |
Characteristics
XHE | BBP | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | VIRTUS Investment Partners |
| Benchmark | S&P Health Care Equipment Select Industry Index | LifeSci Biotechnology Products Index |
| N° of holdings | 67 | 66 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 26, 2011 | December 16, 2014 |
| ESG | No | No |
Advertisement
Exposure
Countries
XHE
USA
93.57%
Other
6.43%
BBP
USA
85.98%
Other
14.02%
Sectors
XHE
Healthcare
97.47%
Other
2.53%
BBP
Healthcare
98.44%
Other
1.56%
Diversification
XHE
Total weight of top 15 holdings out of 15
30.96%
BBP
Total weight of top 15 holdings out of 15
31.08%
Top 15 holdings
Data as of August 31, 2026
XHE
AtriCure, Inc.
2.59%
Strive, Inc. (United States)
2.47%
Inspire Medical Systems, Inc.
2.19%
Glaukos Corp.
2.16%
Butterfly Network, Inc.
2.15%
CONMED Corp.
2.02%
Integer Holdings Corp.
2.02%
Tandem Diabetes Care, Inc.
2.00%
Merit Medical Systems, Inc.
1.99%
Artivion, Inc.
1.94%
Haemonetics Corp.
1.93%
UFP Technologies, Inc.
1.89%
Baxter International, Inc.
1.88%
Becton, Dickinson & Co.
1.87%
Neogen Corp.
1.86%
BBP
Moderna, Inc.
3.58%
Crinetics Pharmaceuticals, Inc.
2.94%
Omeros Corp.
2.49%
Iovance Biotherapeutics, Inc.
2.36%
Verastem, Inc.
2.15%
Precigen, Inc.
1.99%
Halozyme Therapeutics, Inc.
1.84%
Zai Lab Ltd.
1.82%
Kiniksa Pharmaceuticals International Plc
1.81%
Kura Oncology, Inc.
1.72%
BeOne Medicines Ltd.
1.70%
Rigel Pharmaceuticals, Inc.
1.69%
Nuvation Bio, Inc.
1.69%
ACADIA Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
Frequently asked questions about XHE and BBP
How have the XHE and BBP ETFs performed in 2026?
As of October 23, 2026, XHE is up 5.54% year-to-date (YTD), while BBP has returned 28.1%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: XHE or BBP?
Year-to-date, the XHE ETF saw -$11M in flows, compared to +$66M for BBP.
Which ETF is more volatile: XHE or BBP?
Over the past year, XHE had a volatility of 22.71%, while BBP experienced 26.47%.
Which ETF is bigger: XHE or BBP?
As of October 23, 2026, XHE holds $151.14 M in assets under management (AUM), while BBP manages $127.72 M.
What sectors do the XHE and BBP ETFs invest in?
XHE leans toward sectors like Healthcare. Meanwhile, BBP focuses on Healthcare.
What are the top holdings of the XHE ETF and BBP ETF?
XHE top holdings include AtriCure, Inc., Strive, Inc. (United States) and Inspire Medical Systems, Inc.. BBP holds in its top three: Moderna, Inc., Crinetics Pharmaceuticals, Inc. and Omeros Corp..
Which ETF is more diversified: XHE or BBP?
XHE holds 67 securities with 30.96% of its assets in the top 15. BBP has 66 securities and a top 15 weight of 31.08%.
Advertisement
Advertisement
